Valvular & structural heart disease

Echocardiographic Outcomes After Transcatheter Edge-to-Edge Repair in Patients With Isolated Tricuspid Regurgitation: The Tri.Fr Trial

JACC Cardiovasc ImagingPublished Secondary analysis of the Tri.Fr randomised trial

Authors' conclusion

Although T-TEER can decrease TR severity, its impact on conventional RV function parameters and RV-pulmonary artery coupling remains limited. RV functional recovery has a smaller influence on clinical outcomes at 1 year compared with achieving optimal reduction in TR severity.

Study context

Population
Patients with isolated severe secondary tricuspid regurgitation (TR) (aged 78 ± 5 years; 53.7% women)
Participants
300 patients
Comparison
Tricuspid transcatheter edge-to-edge repair (T-TEER) + guideline-directed medical therapy (GDMT) vs GDMT
  • T-TEER + GDMTn = 152
  • GDMTn = 148reference
Primary endpoint
Changes in echocardiographic parameters (RV function), overall and by TR reduction
Follow-up
Baseline to 1 year
Methodological detailscentralized echocardiographic core laboratory
  • Centralized echocardiographic core laboratory

Primary result

As reported in the abstract

RV function parameters · 1 year
  • T-TEER + GDMT: significant decrease in most right ventricular (RV) function parameters
  • GDMT: no significant changes in RV metrics

Further findings

Right atrial volume index by clinical composite score change · 1 year

P = 0.004

Clinical composite score by TR reduction

Improved progressively with each successive grade of TR reduction
Positive effect of T-TEER irrespective of baseline right atrial volume but only with normal RV-pulmonary artery coupling (TAPSE/SPAP ratio ≥0.40)

Original publication

Echocardiographic Outcomes After Transcatheter Edge-to-Edge Repair in Patients With Isolated Tricuspid Regurgitation: The Tri.Fr Trial. JACC Cardiovasc Imaging. Published 19 November 2025. doi:10.1016/j.jcmg.2025.09.010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.